Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China
· Delayed Price · Currency is CNY 51.90
-1.19 (-2.24%)
Apr 29, 2026, 3:04 PM CST
SHE:002294 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 1,080 | 968.43 | 1,125 | 1,322 | 2,670 | 3,236 | Upgrade
|
| Short-Term Investments | - | 1,433 | 988.85 | 695.51 | 531.58 | - | Upgrade
|
| Trading Asset Securities | 745.87 | 688.98 | 733.86 | 186.06 | 328.36 | 60 | Upgrade
|
| Cash & Short-Term Investments | 1,826 | 3,091 | 2,848 | 2,204 | 3,530 | 3,296 | Upgrade
|
| Cash Growth | -32.50% | 8.52% | 29.25% | -37.58% | 7.12% | 205.25% | Upgrade
|
| Accounts Receivable | 932.67 | 850.55 | 565.87 | 545.38 | 557.72 | 474.03 | Upgrade
|
| Other Receivables | 26.94 | 30.87 | 23.85 | 21.01 | 23.4 | 155.48 | Upgrade
|
| Receivables | 959.61 | 881.42 | 589.72 | 566.39 | 581.12 | 629.51 | Upgrade
|
| Inventory | 561.5 | 548.19 | 506.76 | 490.86 | 543.53 | 420.45 | Upgrade
|
| Other Current Assets | 954.09 | 62.53 | 80.02 | 52.43 | 56.36 | 58 | Upgrade
|
| Total Current Assets | 4,301 | 4,583 | 4,025 | 3,313 | 4,711 | 4,404 | Upgrade
|
| Property, Plant & Equipment | 1,547 | 1,532 | 1,430 | 1,457 | 1,506 | 1,638 | Upgrade
|
| Long-Term Investments | 508.06 | 907.01 | 1,492 | 1,701 | 963.07 | 854.48 | Upgrade
|
| Goodwill | 219.49 | 219.49 | 10.91 | 10.91 | 60.53 | 87.14 | Upgrade
|
| Other Intangible Assets | 1,350 | 1,411 | 1,335 | 1,318 | 965.46 | 1,048 | Upgrade
|
| Long-Term Deferred Tax Assets | 217.91 | 215.64 | 151.24 | 87.4 | 88.42 | 82.01 | Upgrade
|
| Long-Term Deferred Charges | 2,148 | 1,996 | 1,597 | 1,416 | 1,344 | 1,047 | Upgrade
|
| Other Long-Term Assets | 1,114 | 433.8 | 424.77 | 93.31 | 116.64 | 83.09 | Upgrade
|
| Total Assets | 11,405 | 11,298 | 10,466 | 9,397 | 9,755 | 9,244 | Upgrade
|
| Accounts Payable | 184.54 | 184.79 | 126.09 | 156.01 | 219.65 | 187.67 | Upgrade
|
| Accrued Expenses | 173.93 | 906.58 | 716.68 | 491.34 | 558.35 | 487.02 | Upgrade
|
| Short-Term Debt | 152.22 | 263.34 | 120 | 40 | 177.19 | 63 | Upgrade
|
| Current Portion of Leases | - | 5.86 | 9.7 | 10.93 | 11.46 | 6.99 | Upgrade
|
| Current Income Taxes Payable | 100.71 | 25.96 | 7.15 | 10.49 | 28.92 | 37.2 | Upgrade
|
| Current Unearned Revenue | 49.17 | 48.94 | 39.35 | 29.55 | 42.66 | 97.99 | Upgrade
|
| Other Current Liabilities | 1,181 | 578.56 | 94 | 76.77 | 565.4 | 132.98 | Upgrade
|
| Total Current Liabilities | 1,842 | 2,014 | 1,113 | 815.08 | 1,604 | 1,013 | Upgrade
|
| Long-Term Debt | 68.6 | - | - | - | - | - | Upgrade
|
| Long-Term Leases | 19.39 | 20.98 | 4.18 | 12.54 | 19.58 | 9.11 | Upgrade
|
| Long-Term Unearned Revenue | 146.8 | 149.12 | 142.04 | 84.11 | 98.53 | 93.71 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 31.26 | 32.16 | 20.97 | 13.04 | 27.18 | - | Upgrade
|
| Other Long-Term Liabilities | 27.54 | 27.54 | 433.14 | 416.47 | 29.64 | 82.57 | Upgrade
|
| Total Liabilities | 2,135 | 2,244 | 1,713 | 1,341 | 1,779 | 1,198 | Upgrade
|
| Common Stock | 1,115 | 1,115 | 1,115 | 1,115 | 1,115 | 1,115 | Upgrade
|
| Additional Paid-In Capital | 2,084 | 2,081 | 1,928 | 1,900 | 1,866 | 1,930 | Upgrade
|
| Retained Earnings | 5,946 | 5,720 | 5,620 | 5,564 | 5,529 | 5,330 | Upgrade
|
| Treasury Stock | - | - | - | -602.16 | -602.16 | -327.86 | Upgrade
|
| Comprehensive Income & Other | 3.99 | 16.85 | 49.3 | 42.22 | 33.24 | -13.41 | Upgrade
|
| Total Common Equity | 9,148 | 8,933 | 8,712 | 8,019 | 7,941 | 8,034 | Upgrade
|
| Minority Interest | 121.69 | 120.84 | 40.17 | 36.43 | 35.81 | 11.91 | Upgrade
|
| Shareholders' Equity | 9,270 | 9,054 | 8,752 | 8,055 | 7,977 | 8,046 | Upgrade
|
| Total Liabilities & Equity | 11,405 | 11,298 | 10,466 | 9,397 | 9,755 | 9,244 | Upgrade
|
| Total Debt | 240.21 | 290.19 | 133.88 | 63.47 | 208.23 | 79.1 | Upgrade
|
| Net Cash (Debt) | 1,586 | 2,801 | 2,714 | 2,140 | 3,322 | 3,217 | Upgrade
|
| Net Cash Growth | -37.86% | 3.18% | 26.83% | -35.58% | 3.28% | 366.56% | Upgrade
|
| Net Cash Per Share | 1.41 | 2.49 | 2.44 | 1.92 | 3.02 | 3.01 | Upgrade
|
| Filing Date Shares Outstanding | 1,115 | 1,115 | 1,115 | 1,091 | 1,091 | 1,103 | Upgrade
|
| Total Common Shares Outstanding | 1,115 | 1,115 | 1,115 | 1,091 | 1,091 | 1,103 | Upgrade
|
| Working Capital | 2,460 | 2,569 | 2,912 | 2,498 | 3,108 | 3,391 | Upgrade
|
| Book Value Per Share | 8.21 | 8.01 | 7.81 | 7.35 | 7.28 | 7.29 | Upgrade
|
| Tangible Book Value | 7,579 | 7,303 | 7,366 | 6,690 | 6,915 | 6,898 | Upgrade
|
| Tangible Book Value Per Share | 6.80 | 6.55 | 6.61 | 6.13 | 6.34 | 6.26 | Upgrade
|
| Buildings | - | 1,266 | 1,222 | 1,218 | 1,208 | 1,218 | Upgrade
|
| Machinery | - | 1,321 | 1,258 | 1,203 | 1,138 | 1,109 | Upgrade
|
| Construction In Progress | - | 173.32 | 62.33 | 34.35 | 37.6 | 94.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.